The demonstration that interleukin 2 (IL-2) is a lectin specific for o
ligomannosides allows to understand a new function for this cytokine:
as a bifunctional molecule when bound to its receptor beta, IL-2 assoc
iates the latter which the CD3/TCR complex, interacting with oligosacc
harides of CD3 through its carbohydrate-recognition domain (Zanetta et
al., 1996, Biochem. J., 318, 49-53). This induces the tyrosine phosph
orylation of the IL-2R beta by p56(lck), the first step of the IL-2-de
pendent signaling. Since this specific association is disrupted in vit
ro by oligomannosides with five and six mannose residues, we made the
hypothesis that pathogenic cells or microorganisms could bind IL-2, co
nsequently disturbing the IL-2-dependent response. This study shows th
at the pathogenic yeast Candida albicans (in contrast with nonpathogen
ic yeasts) binds high amounts of IL-2 as did cancer cells. In contrast
with cancer cells, yeasts do not bind the Man(6)GlcNAc(2)-specific le
ctin CSL, an endogenous ''amplifier of activation signals''.